Evaluation of fluralaner and afoxolaner treatments to control flea populations, reduce pruritus and minimize dermatologic lesions in naturally infested dogs in private residences in west central Florida USA

Table 6 Assessment of skin lesions using the Canine Atopic Dermatitis Extent and Severity Index-4 (CADESI-4) scale for dogs naturally infested with fleas and administered either fluralaner or afoxolaner oral treatments

^aIn both groups dogs were treated on day 0. In the afoxolaner group, dogs were also treated once between days 28–30 and once between days 54–60
^bDogs were orally administered fluralaner chews (Bravecto® Merck Animal Health) according to label directions
^cDogs were orally administered afoxolaner chewables (NexGard® Merial, Inc.) according to label directions
^dArithmetic mean Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4 scores (Olivry et al. Vet Dermatol 25(2):77–85, 2014)
^e{(Day 0 arithmetic mean CADESI-4 score – day x arithmetic mean CADESI-4 score)/day 0 arithmetic mean CADESI-4 score)} x 100

ISSN: 1756-3305